The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

Hypertrophic cardiomyopathy (HCM) is an important genetic heart muscle disease for which
prevalence in the general population has not been completely resolved. For the past 20 …

Aim This executive summary of the hypertrophic cardiomyopathy clinical practice guideline
provides recommendations and algorithms for clinicians to diagnose and manage …

ContextRecently, the implantable cardioverter-defibrillator (ICD) has been promoted for
prevention of sudden death in hypertrophic cardiomyopathy (HCM). However, the effectiveness …

Background Sudden cardiac death among children and young adults is a devastating event.
We performed a prospective, population-based, clinical and genetic study of sudden …

Hypertrophic cardiomyopathy (HCM) is the most common familial heart disease with vast
genetic heterogeneity, demonstrated over the past 20 years. Mutations in 11 or more genes …

Hypertrophic cardiomyopathy (HCM) is a common inherited heart disease with diverse
phenotypic and genetic expression, clinical presentation, and natural history. HCM has been …

Dilated cardiomyopathy is defined by the presence of left ventricular dilatation and contractile
dysfunction. Genetic mutations involving genes that encode cytoskeletal, sarcomere, and …

Skeletal muscle hypertrophy and regeneration are important adaptive responses to both
physical activity and pathological stimuli 1 . Failure to maintain these processes underlies the …

Objectives: To determine the causes of sudden cardiac death in people aged 35 years or
younger. Design and setting: A review of all autopsies performed between 1 January 1994 and …